NanoString Technologies Inc (NASDAQ:NSTG) - Share price


Stock Report

NanoString Technologies Inc NSTG

Last Price
$57.69

Day Change
3.19|5.85%

As of 17/09/2021
16:19:20 EDT | USD
Minimum 15 Minutes Delay.

Last Close54.50
Day Range54.09 - 57.87
Mkt Cap2.63Bil
52-Wk Range34.31 - 86.42
Yield %-
ISINUS63009R1095
Volume789,280
P/E-
P/S18.52
P/CF-32.68

Share Price

Financials
201820192020
More ...
Income Statement
Revenue106.73125.57117.32
Operating Income-69.39-82.70-88.05
Net Income-77.40-40.70-110.08
Basic EPS-2.78-1.18-2.82
Avg. Diluted Shares Outstanding283539
Balance Sheet
Current Assets131.71212.61498.98
Non Current Assets15.8547.1545.22
Total Assets147.56259.75544.20
Current Liabilities43.1244.9937.10
Total Liabilities110.69155.60237.25
Total Equity36.87104.15306.95
Cash Flow
Operating Cash Flow-54.07-89.42-81.66
Capital Expenditure-4.49-7.89-7.46
Free Cash Flow-58.55-97.31-89.12

In millions, except "Basic EPS". Currency is USD.

Company Profile

NanoString Technologies Inc is engaged in the development, manufacturing and commercialization of instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its core technology includes proprietary chemistries that enable the labeling and counting of single molecules. The firm uses its technology to develop tools for scientific and clinical research, primarily in the fields of genomics and proteomics. It offers two product platforms such as nCounter Analysis System or nCounter, and GeoMx Digital Spatial Profiler or DSP system both include instruments, related consumables, and software. NanoString Technologies generates revenue from the sale of products and related services and collaborations.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

579
Key Stats
More ...
Price/Earning TTM-23.90
Price/Book11.29
Price/Sales TTM17.49
Rev Growth (3 year avg)0.69
EPS Growth (3 year avg)-
Operating Margin % TTM-75.05
Net Margin % TTM-93.83
ROE TTM-53.55
Debt/Equity0.65
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.